Evidence-Based Guideline: IV Immunoglobulin in the Treatment of Neuromuscular Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology | Zendy

AI Assistant Blog Pricing

Evidence-Based Guideline: IV Immunoglobulin in the Treatment of Neuromuscular Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.